Log In
BCIQ
Print this Print this
 

Dapivirine Vaginal Ring

  Manage Alerts
Collapse Summary General Information
Company International Partnership for Microbicides
DescriptionOnce-monthly vaginal ring containing 25 mg dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationHIV / AIDS
Indication DetailsPrevent HIV-1 infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today